5AM Venture Management, LLC reported 16 holdings worth US$288M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
5AM Venture Management, LLC reported 16 holdings worth US$288M as of Jun 30, 2026. Largest: Maplight Therapeutics, Inc., Tyra Biosciences, Inc. and Entrada Therapeutics, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 16
- Value as reported
- US$288M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Maplight Therapeutics, Inc. | 950K | US$34M | 11.8% |
| Tyra Biosciences, Inc. | 1.03M | US$32.9M | 11.4% |
| Entrada Therapeutics, Inc. | 4.06M | US$29.9M | 10.4% |
| Camp4 Therapeutics Corporation | 5.87M | US$25.6M | 8.9% |
| Artiva Biotherapeutics, Inc. | 2.35M | US$22.8M | 7.9% |
| Tectonic Therapeutic, Inc. | 607K | US$20.9M | 7.2% |
| Zentalis Pharmaceuticals, Inc. | 3.95M | US$19.1M | 6.7% |
| Celldex Therapeutics, Inc. | 497K | US$18.5M | 6.4% |
| Eyepoint, Inc. | 1.05M | US$15M | 5.2% |
| Biohaven Ltd. | 739K | US$11M | 3.8% |
| Surrozen, Inc. | 271K | US$7.04M | 2.4% |
| Skye Bioscience, Inc. | 9.68M | US$6.71M | 2.3% |
| Alx Oncology Holdings Inc. | 3.06M | US$6.33M | 2.2% |
| Protara Therapeutics, Inc. | 1.37M | US$5.23M | 1.8% |
| Erasca, Inc. | 0 | US$0 | 0.00% |
| Rallybio Corporation | 0 | US$0 | 0.00% |